[The use of betaserk in patients with cochlear-vestibular disorders].
20-year experience with 220 cases of cochleovestibular disorders treated with betaserk shows high efficacy of this drug in the above patients, especially at initial stages of Meniere's disease. Betaserk is recommended for wide outpatient practice.
Kadymov
M I
MI
Poliakova
T S
TS
Vladimirova
T N
TN
D000368:Aged; D001621:Betahistine / Q000627:therapeutic use*; D015834:Cochlear Diseases / Q000188:drug therapy*; D017442:Histamine Agonists / Q000627:therapeutic use*; D006801:Humans; D008575:Meniere Disease / Q000188:drug therapy; D015837:Vestibular Diseases / Q000188:drug therapy*
D017442:Histamine Agonists; D001621:Betahistine